Mild Traumatic Brain Injury in Elderly Patients Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis
Juliette A L Santing 1, Ying Xing Lee 1, Joukje van der Naalt 2, Crispijn L van den Brand 3, Korné Jellema 1
Affiliations expand
- PMID: 35057639
- DOI: 10.1089/neu.2021.0435
Abstract
The aim of this work was to conduct a systematic review and meta-analysis of studies reporting on the risk of traumatic intracerebral hemorrhage (tICH), the course of tICH, and its treatment and mortality rates in elderly mild traumatic brain injury (mTBI) patients using direct oral anticoagulants (DOACs). We consulted PubMed and Embase for relevant cohort and case-control studies with a control group. Two authors independently selected studies, assessed methodological quality, and extracted outcome data. Estimates were pooled with the Mantel-Haenszel random-effects method. We identified 16 articles comprising 3671 elderly mTBI patients using DOACs. Use of DOACs was associated with a reduced risk of tICH compared to the use of vitamin K antagonists (VKAs; odds ratio [OR], 0.44; 95% confidence interval [CI], 0.29-0.65; I2 = 22%) and a similar risk compared to the use of antiplatelet therapy (APT; OR, 0.98; 95% CI, 0.39-2.44; I2 = 0%). Reversal agent use and neurosurgical intervention rate were lower in patients using DOACs compared to patients using VKAs (OR, 0.10; 95% CI, 0.06-0.16; I2 = 0% and OR, 0.37; 95% CI, 0.21-0.67; I2 = 0%, respectively). There was no significant difference in neurosurgical intervention rate between patients who used DOACs versus patients who used APT (OR, 0.58; 95% CI, 0.15-2.21; I2 = 41%) or no antithrombotic therapy (OR, 0.76; 95% CI, 0.20-2.86; I2 = 23%). ICH progression, risk of delayed ICH, and TBI-related in-hospital mortality were comparable among treatment groups. The present study indicates that elderly patients using DOACs have a lower risk of adverse outcome compared to patients using VKAs and a similar risk compared to patients using APT after mTBI.
Keywords: DOAC; VKA; elderly; intracerebral hemorrhage; mild traumatic brain injury; minor head injury reversal agent.
Similar articles
- Consequences of pre-injury utilization of direct oral anticoagulants in patients with traumatic brain injury: A systematic review and meta-analysis.Nederpelt CJ, van der Aalst SJM, Rosenthal MG, Krijnen P, Huisman MV, Peul WC, Schipper IB.J Trauma Acute Care Surg. 2020 Jan;88(1):186-194. doi: 10.1097/TA.0000000000002518.PMID: 31688828
- Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.Shin SS, Marsh EB, Ali H, Nyquist PA, Hanley DF, Ziai WC.Neurocrit Care. 2020 Apr;32(2):407-418. doi: 10.1007/s12028-019-00898-y.PMID: 32034657
- The Effect of Direct Oral Anti-Coagulants on Delayed Traumatic Intracranial Hemorrhage After Mild Traumatic Brain Injury: A Systematic Review.Hickey S, Hickman ZL, Conway J, Giwa A.J Emerg Med. 2021 Mar;60(3):321-330. doi: 10.1016/j.jemermed.2020.10.037. Epub 2020 Dec 31.PMID: 33390300
- Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA.Cochrane Database Syst Rev. 2018 Jun 19;6(6):CD006650. doi: 10.1002/14651858.CD006650.pub5.PMID: 29920657 Free PMC article. Review.
- Systematic Review and Meta-Analysis: Is Pre-Injury Antiplatelet Therapy Associated with Traumatic Intracranial Hemorrhage?van den Brand CL, Tolido T, Rambach AH, Hunink MG, Patka P, Jellema K.J Neurotrauma. 2017 Jan 1;34(1):1-7. doi: 10.1089/neu.2015.4393. Epub 2016 May 9.PMID: 26979949 Review.
Cited by
- Does Antithrombotic Therapy Affect Outcomes in Major Trauma Patients? A Retrospective Cohort Study from a Tertiary Trauma Centre.Sartini S, Spadaro M, Cutuli O, Castellani L, Sartini M, Cristina ML, Canepa P, Tognoni C, Lo A, Canata L, Rosso M, Arboscello E.J Clin Med. 2022 Sep 29;11(19):5764. doi: 10.3390/jcm11195764.PMID: 36233632 Free PMC article.
